DNA: the balance sheet

MyFinsight

For the quarter ending 2025-09-30, DNA has $1,189,165K in assets. $629,382K in debts. $111,065K in cash and cash equivalents.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Balance Sheets	2025-09-30	2025-06-30
Cash and cash equivalents	111,065	203,566
Marketable securities	350,797	270,125
Accounts receivable, net	21,430	22,152
Accounts receivable - related parties	929	974
Prepaid expenses and other current assets	21,861	26,208
Total current assets	506,082	523,025
Property, plant and equipment, net	176,579	186,354
Operating lease right-of-use assets	368,213	375,796
Investments	30,175	32,662
Intangible assets, net	61,522	66,152
Other non-current assets	46,594	47,020
Total assets	1,189,165	1,231,009

Accounts payable	10,704	11,202
Deferred revenue (includes 311 and 795 from related parties)	25,236	28,287
Accrued expenses and other current liabilities	79,341	57,231
Total current liabilities	115,281	96,720
Deferred revenue, net of current portion (includes 64,786 and 72,260 from related parties)	74,072	74,566
Operating lease liabilities, non-current	422,870	428,827
Other non-current liabilities	17,159	17,944
Total liabilities	629,382	618,057
Common stock, 0.0001 par value (note 8)	6	6
Additional paid-in capital	6,627,350	6,600,107
Accumulated deficit	-6,069,569	-5,988,814
Accumulated other comprehensive income (loss)	1,996	1,653
Total stockholders equity	559,783	612,952
Total liabilities and stockholders equity	1,189,165	1,231,009